We are fundraising the cost for 140 ME-sufferers to Haukeland Hospital, cancer ward, to be a part of a clinical trial on Rituxan. The cost is 1,2 million USD, 55 000 Norwegian kroner each. We are going to do it in 90 days. You can read about why we are doing it, too.
The Rituxan study at Haukeland Hospital, presented in PlosOne autumn 2011, showed the most promising results worldwide for ME/CFS-sufferers. 2/3 had good or moderat effect. The bigger RCT-study has not had sufficient economical support from the official healthcaresystem to continue their research.
ME/CFS is a poorly understood, but debiliating, nevroimmunological illness with none or little treatment, that affect hundreds of thousands people world wide. Have you ever thought about how much the society would save just by getting a few of those sufferers back in work and as participients of the community?
What if it turns out that the research you, as an individual support, will be a breakthrough in the medical field? What if you are one of those people who in few years can say that, yes, I was a part of it! This might be your chance. The patients, the families, the friends pass those well-established channels and contributes funds directly to the research projects we want to support, so that they become a reality. Do you want to be a part of it?
1.2 USD. 140 patients. 90 days.